Glaucoma patients may soon ditch eye drops after cataract surgery
NCT ID NCT07218796
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase 3 trial tests a bimatoprost implant placed inside the eye during cataract surgery to lower eye pressure in people with glaucoma or high eye pressure. About 400 participants will receive either the implant with a special lens or standard eye drops. The goal is to see if the implant works as well as or better than daily drops.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- bimatoprost implant
- What this could lead to
- If successful, this could offer a long-term, drop-free way to control eye pressure after cataract surgery for people with glaucoma.
- What could go wrong
- This is still in testing, so it may not work better than standard drops. There are also risks from the implant procedure itself, like infection or inflammation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CATARACT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
R and R Eye Research, LLC
RECRUITINGSan Antonio, Texas, 78229, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple stress ball or favorite tune replace anxiety meds during eye surgery?
- Can a new eye test match the gold standard for glaucoma?
- Can a bangkok community eye check reveal hidden glaucoma risks?
- AI eye exam: a new hope for early glaucoma detection?
- Can a tiny eye implant replace glaucoma drops?
- Can a new tube implant surgery outperform standard glaucoma surgery?